Precision BioSciences Appoints Cindy Atwell as Chief Development and Business Officer and Cassie Gorsuch, PhD as Chief Scientific Officer
Position
Chief Scientific Officer
Company
Precision BioSciences
DurhamBiotechnologyHealth CareGeneticsTherapeuticsDescription
Precision BioSciences announced the appointment of Cindy Atwell as Chief Development and Business Officer, where she will oversee all development functions including clinical, translational, regulatory, and business development. Additionally, Cassie Gorsuch, PhD has been promoted to Chief Scientific Officer, responsible for non-clinical development and gene therapy discovery.
Quick answer
Precision BioSciences Appoints Cindy Atwell as Chief Development and Business Officer and Cassie Gorsuch, PhD as Chief Scientific Officer (January 29, 2025). Precision BioSciences is based in Durham, North Carolina, United States.
- Who is the new Chief Scientific Officer at Precision BioSciences?
- Precision BioSciences named Cassie Gorsuch Chief Scientific Officer, announced January 29, 2025.
- What did Precision BioSciences announce on January 29, 2025?
- Precision BioSciences announced the appointment of Cindy Atwell as Chief Development and Business Officer, where she will oversee all development functions including clinical, translational, regulatory, and business development. Additionally, Cassie Gorsuch, PhD has been promoted to Chief Scientific Officer, responsible for non-clinical development and gene therapy discovery.
- What does Precision BioSciences do?
- Precision is a clinical stage gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform that differs from other technologies in the way it cuts, its smaller...
- Where is Precision BioSciences based?
- Precision BioSciences is based in Durham, North Carolina, United States.
- Which similar companies made leadership changes around the same time?
- Lexeo Therapeutics (December 19, 2024), Daiichi Sankyo (January 31, 2025), Commit Biologics (February 2, 2025) and NGM Bio (February 4, 2025) also announced leadership changes within 45 days of Precision BioSciences.
Source: Fundz verified event record.
Other recent leadership changes in Genetics and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Lexeo Therapeutics Appoints Dr. Kyle Rasbach as Chief Financial Officer (December 19, 2024)
- Daiichi Sankyo Names Hiroyuki Okuzawa as Chief Executive Officer (CEO) succeeding Sunao Manabe (January 31, 2025)
- Commit Biologics Appoints Mikkel Wandahl Pedersen as Interim CEO (February 2, 2025)
- NGM Bio Appoints Dr. Wendy Yeh as Chief Medical Officer, Dr. Hsiao D. Lieu Steps Down (February 4, 2025)
- Uvax Bio Appoints Kevin O'Neill as Interim Chief Executive Officer (CEO) (February 4, 2025)
- Pliant Therapeutics Names Delphine Imbert as Chief Technical Officer (January 22, 2025)
Who to call at Precision BioSciences, and when
A new leader at Precision BioSciences brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Precision BioSciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Precision BioSciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Precision BioSciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Precision BioSciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Precision BioSciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.